Dr. Shi is managing director of Lilly Asian Ventures, andfounding member of InnoCentive, Inc., a Lilly Ventures portfolio company.
Based in Shanghai, Yi oversees Lilly Asia Ventures since its founding in 2008.
Prior to his current role, Yi worked at Eli Lilly and Company with a diverse set of experiences including venture start-up, marketing, business development licensing, and corporate strategy.Currently, he serves on the Board of HD Bioscience, Chipscreen, Beta Pharma, BrightGene Biomedical, Novast, and SinqiPharma.
education includes a Ph.D. in biochemistry and a Master of Business Administration degree, both from Duke University.
He also earned a Bachelor of Sciences in Biology from the University of Science and Technology of China.
Yi Shi (Lilly Asia Ventures)